Preventing and treating acute gout attacks across the clinical spectrum: a roundtable discussion.
Mandell
Brian F
BF
Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH 44195, USA. mandelb@ccf.org
Edwards
N Lawrence
NL
Sundy
John S
JS
Simkin
Peter A
PA
Pile
James C
JC
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001707:Biopsy, Needle; D003078:Colchicine / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007375:Interleukin-1 / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D013582:Synovial Fluid / Q000737:chemistry; D014527:Uric Acid / Q000032:analysis
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D007375:Interleukin-1; D009294:Narcotics; D014527:Uric Acid; D003078:Colchicine